A Trial of TTA-121 on Autism Spectrum Disorder

NCT03466671 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Autism Spectrum Disorder

Interventions

DRUG: TTA-121

Sponsor

Hamamatsu University

Collaborators

[object Object]